{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:24:15Z","timestamp":1779301455122,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074443"],"award-info":[{"award-number":["82074443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03191-x","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T22:01:48Z","timestamp":1719871308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Plasma proteins and inflammatory dermatoses: proteome-wide Mendelian randomization and colocalization analyses"],"prefix":"10.1007","volume":"316","author":[{"given":"Mengsong","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mulan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"issue":"2","key":"3191_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jaci.2012.12.672","volume":"131","author":"L Schneider","year":"2013","unstructured":"Schneider L, Tilles S, Lio P, Boguniewicz M, Beck L, LeBovidge J et al (2013) Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol 131(2):295\u2013299 e1-27","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"3191_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","volume":"17","author":"MRW Barber","year":"2021","unstructured":"Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY et al (2021) Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol 17(9):515\u2013532","journal-title":"Nat Rev Rheumatol"},{"key":"3191_CR3","doi-asserted-by":"publisher","first-page":"743180","DOI":"10.3389\/fmed.2021.743180","volume":"8","author":"G Damiani","year":"2021","unstructured":"Damiani G, Bragazzi NL, Karimkhani Aksut C, Wu D, Alicandro G, McGonagle D et al (2021) The Global, Regional, and National Burden of Psoriasis: results and insights from the global burden of Disease 2019 study. Front Med 8:743180","journal-title":"Front Med"},{"issue":"4","key":"3191_CR4","doi-asserted-by":"publisher","first-page":"adv00433","DOI":"10.2340\/00015555-3796","volume":"101","author":"G Peck","year":"2021","unstructured":"Peck G, Hashim MJ, Shaughnessy C, Muddasani S, Elsayed NA, Fleischer AB (2021) Jr. Global Epidemiology of Urticaria: increasing Burden among children, females and low-income regions. Acta dermato-venereologica 101(4):adv00433","journal-title":"Acta dermato-venereologica"},{"issue":"17","key":"3191_CR5","doi-asserted-by":"publisher","first-page":"adv00303","DOI":"10.2340\/00015555-3664","volume":"100","author":"P Halonen","year":"2020","unstructured":"Halonen P, Jakobsson M, Heikinheimo O, Gissler M, Pukkala E (2020) Incidence of Lichen Planus and subsequent mortality in Finnish women. Acta dermato-venereologica 100(17):adv00303","journal-title":"Acta dermato-venereologica"},{"issue":"7","key":"3191_CR6","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1080\/09546634.2022.2089331","volume":"33","author":"H Husein-ElAhmed","year":"2022","unstructured":"Husein-ElAhmed H, Steinhoff M (2022) Bullous pemphigoid induced by biologic drugs in psoriasis: a systematic review. J Dermatolog Treat 33(7):2886\u20132893","journal-title":"J Dermatolog Treat"},{"issue":"11","key":"3191_CR7","doi-asserted-by":"publisher","first-page":"e0241575","DOI":"10.1371\/journal.pone.0241575","volume":"15","author":"LF Iannone","year":"2020","unstructured":"Iannone LF, Bennardo L, Palleria C, Roberti R, De Sarro C, Naturale MD et al (2020) Safety profile of biologic drugs for psoriasis in clinical practice: an Italian prospective pharmacovigilance study. PLoS ONE 15(11):e0241575","journal-title":"PLoS ONE"},{"issue":"3","key":"3191_CR8","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jaip.2020.11.034","volume":"9","author":"T Ratchataswan","year":"2021","unstructured":"Ratchataswan T, Banzon TM, Thyssen JP, Weidinger S, Guttman-Yassky E, Phipatanakul W (2021) Biologics for treatment of atopic dermatitis: current status and future Prospect. J Allergy Clin Immunol Pract 9(3):1053\u20131065","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"3191_CR9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jaip.2020.11.043","volume":"9","author":"M Maurer","year":"2021","unstructured":"Maurer M, Khan DA, Elieh Ali Komi D, Kaplan AP (2021) Biologics for the Use in Chronic spontaneous urticaria: when and which. J Allergy Clin Immunol Pract 9(3):1067\u20131078","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"3191_CR10","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.jaad.2023.01.002","volume":"88","author":"A Belzer","year":"2023","unstructured":"Belzer A, Mortlock RD, Pach J, Cohen JM, Leventhal JS (2023) The effect of baseline eczema or psoriasis on the morphology of cutaneous immune-related adverse events due to immune checkpoint inhibitor therapy. J Am Acad Dermatol 88(5):1198\u20131200","journal-title":"J Am Acad Dermatol"},{"key":"3191_CR11","doi-asserted-by":"crossref","unstructured":"Yang DH, Leong PY, Sia SK, Wang YH, Wei JC (2019) Long-term hydroxychloroquine therapy and risk of coronary artery disease in patients with systemic Lupus Erythematosus. J Clin Med. ;8(6)","DOI":"10.3390\/jcm8060796"},{"issue":"6","key":"3191_CR12","first-page":"864","volume":"19","author":"F Solimani","year":"2021","unstructured":"Solimani F, Forchhammer S, Schloegl A, Ghoreschi K, Meier K (2021) Lichen planus - a clinical guide. J Der Deutschen Dermatologischen Gesellschaft = J German Soc Dermatology: JDDG 19(6):864\u2013882","journal-title":"J Der Deutschen Dermatologischen Gesellschaft = J German Soc Dermatology: JDDG"},{"issue":"1","key":"3191_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41576-020-0268-2","volume":"22","author":"K Suhre","year":"2021","unstructured":"Suhre K, McCarthy MI, Schwenk JM (2021) Genetics meets proteomics: perspectives for large population-based studies. Nat Rev Genet 22(1):19\u201337","journal-title":"Nat Rev Genet"},{"issue":"11","key":"3191_CR14","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","volume":"1","author":"NL Anderson","year":"2002","unstructured":"Anderson NL, Anderson NG (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics: MCP 1(11):845\u2013867","journal-title":"Mol Cell Proteomics: MCP"},{"issue":"4","key":"3191_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/bjd.21627","volume":"187","author":"R Ramessur","year":"2022","unstructured":"Ramessur R, Corbett M, Marshall D, Acencio ML, Barbosa IA, Dand N et al (2022) Biomarkers of disease progression in people with psoriasis: a scoping review. Br J Dermatol 187(4):481\u2013493","journal-title":"Br J Dermatol"},{"issue":"suppl1","key":"3191_CR16","first-page":"i32","volume":"56","author":"C Arriens","year":"2017","unstructured":"Arriens C, Wren JD, Munroe ME, Mohan C (2017) Systemic lupus erythematosus biomarkers: the challenging quest. Rheumatology (Oxford) 56(suppl1):i32\u2013i45","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3191_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/cea.12870","volume":"47","author":"P Kolkhir","year":"2017","unstructured":"Kolkhir P, Andr\u00e9 F, Church MK, Maurer M, Metz M (2017) Potential blood biomarkers in chronic spontaneous urticaria. Clin Experimental Allergy: J Br Soc Allergy Clin Immunol 47(1):19\u201336","journal-title":"Clin Experimental Allergy: J Br Soc Allergy Clin Immunol"},{"issue":"6","key":"3191_CR18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1684\/ejd.2018.3443","volume":"28","author":"MN Ghazanfar","year":"2018","unstructured":"Ghazanfar MN, Thomsen SF (2018) D-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria: a focused review. Eur J Dermatology: EJD 28(6):731\u2013735","journal-title":"Eur J Dermatology: EJD"},{"key":"3191_CR19","doi-asserted-by":"publisher","first-page":"850993","DOI":"10.3389\/fimmu.2022.850993","volume":"13","author":"S Peng","year":"2022","unstructured":"Peng S, Zhang T, Zhang S, Tang Q, Yan Y, Feng H (2022) Integrated Bioinformatics and Validation Reveal IL1B and its related molecules as potential biomarkers in chronic spontaneous Urticaria. Front Immunol 13:850993","journal-title":"Front Immunol"},{"key":"3191_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-3-319-99124-5_31","volume-title":"Pain: a Review Guide","author":"AS Hess","year":"2019","unstructured":"Hess AS, Abd-Elsayed A (2019) Observational studies: uses and limitations. In: Abd-Elsayed A (ed) Pain: a Review Guide. Springer International Publishing, Cham, pp 123\u2013125"},{"issue":"3","key":"3191_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jcin.2008.01.008","volume":"1","author":"EL Hannan","year":"2008","unstructured":"Hannan EL (2008) Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations. JACC Cardiovasc Interventions 1(3):211\u2013217","journal-title":"JACC Cardiovasc Interventions"},{"issue":"2","key":"3191_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.therap.2018.11.001","volume":"74","author":"F Gueyffier","year":"2019","unstructured":"Gueyffier F, Cucherat M (2019) The limitations of observation studies for decision making regarding drugs efficacy and safety. Therapie 74(2):181\u2013185","journal-title":"Therapie"},{"issue":"2","key":"3191_CR23","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1365-2753.2010.01382.x","volume":"16","author":"N Cartwright","year":"2010","unstructured":"Cartwright N, Munro E (2010) The limitations of randomized controlled trials in predicting effectiveness. J Eval Clin Pract 16(2):260\u2013266","journal-title":"J Eval Clin Pract"},{"issue":"2","key":"3191_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1161\/CIRCULATIONAHA.116.026324","volume":"135","author":"GA FitzGerald","year":"2017","unstructured":"FitzGerald GA, Imprecision (2017) Limitations to Interpretation of a large Randomized Clinical Trial. Circulation 135(2):113\u2013115","journal-title":"Circulation"},{"issue":"1","key":"3191_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith GD, Ebrahim S (2003) Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32(1):1\u201322","journal-title":"Int J Epidemiol"},{"issue":"19","key":"3191_CR26","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S (2017) Mendelian Randomization Jama 318(19):1925\u20131926","journal-title":"Mendelian Randomization Jama"},{"issue":"12","key":"3191_CR27","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL et al (2021) Large-scale integration of the plasma proteome with genetics and disease. Nat Genet 53(12):1712\u20131721","journal-title":"Nat Genet"},{"issue":"12","key":"3191_CR28","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/ng.3434","volume":"47","author":"J Bentham","year":"2015","unstructured":"Bentham J, Morris DL, Graham DSC, Pinder CL, Tombleson P, Behrens TW et al (2015) Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet 47(12):1457\u20131464","journal-title":"Nat Genet"},{"key":"3191_CR29","doi-asserted-by":"crossref","unstructured":"Assar S, Mohamadzadeh D, Golmohammadi S, Fatahi ZJRR (2021) The association of main blood groups and development of systemic Lupus Erythematosus and its organ involvements","DOI":"10.22631\/rr.2021.69997.1121"},{"key":"3191_CR30","unstructured":"Karimifar M, Moussavi H, Hajihashemi A (2019) Prevalence of ABO and rh blood groups in systemic lupus erythematosus and their association with disease activity. 4(2):e26\u2013e"},{"key":"3191_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2016.06.001","volume":"31","author":"M Patidar","year":"2016","unstructured":"Patidar M, Yadav N, Dalai SK (2016) Interleukin 15: a key cytokine for immunotherapy. Cytokine Growth Factor Rev 31:49\u201359","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"3191_CR32","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1159\/000508515","volume":"181","author":"H Karlen","year":"2020","unstructured":"Karlen H, Yousefi S, Simon HU, Simon D (2020) IL-15 expression pattern in atopic dermatitis. Int Arch Allergy Immunol 181(6):417\u2013421","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"3191_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/blood-2012-04-425306","volume":"120","author":"DJ Cole","year":"2012","unstructured":"Cole DJ, Rubinstein MP (2012) Soluble IL-15\/IL-15R\u03b1 complexes in human serum. Blood 120(1):1\u20132","journal-title":"Blood"},{"issue":"6","key":"3191_CR34","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1021\/bi00599a014","volume":"17","author":"SO Olofsson","year":"1978","unstructured":"Olofsson SO, McConathy WJ, Alaupovic P (1978) Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma. Biochemistry 17(6):1032\u20131036","journal-title":"Biochemistry"},{"issue":"3","key":"3191_CR35","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1074\/jbc.274.3.1814","volume":"274","author":"X Wang","year":"1999","unstructured":"Wang X, Driscoll DM, Morton RE (1999) Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F. J Biol Chem 274(3):1814\u20131820","journal-title":"J Biol Chem"},{"issue":"4","key":"3191_CR36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/MOL.0000000000000688","volume":"31","author":"Y Liu","year":"2020","unstructured":"Liu Y, Morton RE, Apolipoprotein F (2020) A natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism. Curr Opin Lipidol 31(4):194\u2013199","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"3191_CR37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1194\/jlr.M700258-JLR200","volume":"49","author":"RE Morton","year":"2008","unstructured":"Morton RE, Gnizak HM, Greene DJ, Cho KH, Paromov VM (2008) Lipid transfer inhibitor protein (apolipoprotein F) concentration in normolipidemic and hyperlipidemic subjects. J Lipid Res 49(1):127\u2013135","journal-title":"J Lipid Res"},{"issue":"11","key":"3191_CR38","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1194\/jlr.RA119000171","volume":"60","author":"RE Morton","year":"2019","unstructured":"Morton RE, Liu Y, Izem L (2019) ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters. J Lipid Res 60(11):1868\u20131879","journal-title":"J Lipid Res"},{"issue":"6","key":"3191_CR39","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1365-2133.1994.tb03411.x","volume":"130","author":"M Seishima","year":"1994","unstructured":"Seishima M, Seishima M, Mori S, Noma A (1994) Serum lipid and apolipoprotein levels in patients with psoriasis. Br J Dermatol 130(6):738\u2013742","journal-title":"Br J Dermatol"},{"key":"3191_CR40","doi-asserted-by":"crossref","unstructured":"Jacob JT, Coulombe PA, Kwan R, Omary MB (2018) Types I and II keratin intermediate filaments. Cold Spring Harb Perspect Biol. ;10(4)","DOI":"10.1101\/cshperspect.a018275"},{"issue":"3","key":"3191_CR41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1684\/ejd.2017.2985","volume":"27","author":"A Totsuka","year":"2017","unstructured":"Totsuka A, Omori-Miyake M, Kawashima M, Yagi J, Tsunemi Y (2017) Expression of keratin 1, keratin 10, desmoglein 1 and desmocollin 1 in the epidermis: possible downregulation by interleukin-4 and interleukin-13 in atopic dermatitis. Eur J Dermatology: EJD 27(3):247\u2013253","journal-title":"Eur J Dermatology: EJD"},{"key":"3191_CR42","doi-asserted-by":"crossref","unstructured":"Broccardo CJ, Mahaffey SB, Strand M, Reisdorph NA, Leung DY (2009) Peeling off the layers: skin taping and a novel proteomics approach to study atopic dermatitis. J Allergy Clin Immunol 124(5):1113\u20135e1","DOI":"10.1016\/j.jaci.2009.07.057"},{"issue":"2","key":"3191_CR43","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1080\/10773525.2018.1427307","volume":"23","author":"J Douwes","year":"2017","unstructured":"Douwes J, Slater T, Shanthakumar M, McLean D, Firestone RT, Judd L et al (2017) Determinants of hand dermatitis, urticaria and loss of skin barrier function in professional cleaners in New Zealand. Int J Occup Environ Health 23(2):110\u2013119","journal-title":"Int J Occup Environ Health"},{"issue":"12","key":"3191_CR44","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1182\/blood-2009-02-205641","volume":"114","author":"S Heinen","year":"2009","unstructured":"Heinen S, Hartmann A, Lauer N, Wiehl U, Dahse HM, Schirmer S et al (2009) Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood 114(12):2439\u20132447","journal-title":"Blood"},{"issue":"5","key":"3191_CR45","doi-asserted-by":"publisher","first-page":"e12011","DOI":"10.1002\/clt2.12011","volume":"11","author":"M Alizadeh Aghdam","year":"2021","unstructured":"Alizadeh Aghdam M, van den Elzen M, van Os-Medendorp H, van Dijk MR, Knol EF, Knulst AC et al (2021) Systemic and local evidence for complement involvement in chronic spontaneous urticaria. Clin Translational Allergy 11(5):e12011","journal-title":"Clin Translational Allergy"},{"issue":"1","key":"3191_CR46","first-page":"43","volume":"31","author":"H Zhu","year":"2013","unstructured":"Zhu H, Liang B, Li R, Li J, Lin L, Ma S et al (2013) Activation of coagulation, anti-coagulation, fibrinolysis and the complement system in patients with urticaria. Asian Pac J Allergy Immunol 31(1):43\u201350","journal-title":"Asian Pac J Allergy Immunol"},{"key":"3191_CR47","doi-asserted-by":"crossref","unstructured":"Yanase Y, Takahagi S, Ozawa K, Hide M (2021) The role of Coagulation and complement factors for mast cell activation in the pathogenesis of chronic spontaneous Urticaria. Cells. ;10(7)","DOI":"10.3390\/cells10071759"},{"issue":"4","key":"3191_CR48","first-page":"1243","volume":"54","author":"KA Zug","year":"1996","unstructured":"Zug KA, McKay M (1996) Eczematous dermatitis: a practical review. Am Family Phys 54(4):1243\u20131250 53\u2009\u2013\u20094","journal-title":"Am Family Phys"},{"key":"3191_CR49","doi-asserted-by":"publisher","first-page":"1361005","DOI":"10.3389\/fimmu.2024.1361005","volume":"15","author":"M Afshari","year":"2024","unstructured":"Afshari M, Kolackova M, Rosecka M, \u010celakovsk\u00e1 J, Krejsek J (2024) Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches. Front Immunol 15:1361005","journal-title":"Front Immunol"},{"issue":"Pt 22","key":"3191_CR50","first-page":"5269","volume":"125","author":"W Roth","year":"2012","unstructured":"Roth W, Kumar V, Beer HD, Richter M, Wohlenberg C, Reuter U et al (2012) Keratin 1 maintains skin integrity and participates in an inflammatory network in skin through interleukin-18. J Cell Sci 125(Pt 22):5269\u20135279","journal-title":"J Cell Sci"},{"issue":"6","key":"3191_CR51","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/bjd.20975","volume":"186","author":"L Calabrese","year":"2022","unstructured":"Calabrese L, Fiocco Z, Satoh TK, Peris K, French LE (2022) Therapeutic potential of targeting interleukin-1 family cytokines in chronic inflammatory skin diseases. Br J Dermatol 186(6):925\u2013941","journal-title":"Br J Dermatol"},{"key":"3191_CR52","doi-asserted-by":"publisher","first-page":"3090782","DOI":"10.1155\/2017\/3090782","volume":"2017","author":"Y Hu","year":"2017","unstructured":"Hu Y, Wang J, Zhang H, Xie H, Song W, Jiang Q et al (2017) Enhanced expression of IL-18 and IL-18BP in plasma of patients with Eczema: altered expression of IL-18BP and IL-18 receptor on mast cells. Mediat Inflamm 2017:3090782","journal-title":"Mediat Inflamm"},{"key":"3191_CR53","doi-asserted-by":"crossref","unstructured":"Beyer L, Kabatas AS, Mommert S, Stark H, Werfel T, Gutzmer R et al (2022) Histamine activates human eosinophils via H(2)R and H(4)R predominantly in atopic dermatitis patients. Int J Mol Sci. ;23(18)","DOI":"10.3390\/ijms231810294"},{"issue":"3","key":"3191_CR54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1046\/j.1440-1592.2003.00290.x","volume":"52","author":"H Ohnishi","year":"2003","unstructured":"Ohnishi H, Kato Z, Watanabe M, Fukutomi O, Inoue R, Teramoto T et al (2003) Interleukin-18 is associated with the severity of atopic dermatitis. Allergology Int 52(3):123\u2013130","journal-title":"Allergology Int"},{"issue":"4","key":"3191_CR55","first-page":"Wc01","volume":"9","author":"K Zedan","year":"2015","unstructured":"Zedan K, Rasheed Z, Farouk Y, Alzolibani AA, Bin Saif G, Ismail HA et al (2015) Immunoglobulin e, interleukin-18 and interleukin-12 in patients with atopic dermatitis: correlation with disease activity. J Clin Diagn Research: JCDR 9(4):Wc01\u20135","journal-title":"J Clin Diagn Research: JCDR"},{"issue":"9357","key":"3191_CR56","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S0140-6736(03)12520-2","volume":"361","author":"LR Cardon","year":"2003","unstructured":"Cardon LR, Palmer LJ (2003) Population stratification and spurious allelic association. Lancet (London England) 361(9357):598\u2013604","journal-title":"Lancet (London England)"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03191-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03191-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03191-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T20:37:23Z","timestamp":1725914243000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03191-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["3191"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03191-x","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,1]]},"assertion":[{"value":"29 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"443"}}